Overview

A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

Status:
Active, not recruiting
Trial end date:
2027-04-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is see how effective is JNJ-77242113 in participants with moderate to severe plaque psoriasis.
Phase:
Phase 3
Details
Lead Sponsor:
Janssen Research & Development, LLC